Sue Gao

Amgen (United States) — United States

Medicine · Health Sciences

14h-index1.1kcitations22works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(7), Cancer Treatment and Pharmacology(6), Economic and Financial Impacts of Cancer(6), Gastric Cancer Management and Outcomes(5), Platelet Disorders and Treatments(5)

Publications22 total

The impact of infusion reactions associated with monoclonal antibodies in metastatic colorectal cancer: A European perspective
Journal of Oncology Pharmacy Practice·2012· 7 cited
Tumor hormone/HER2 receptor status and pharmacologic treatment of metastatic breast cancer in Western Europe
Current Medical Research and Opinion·2012· 14 cited
Economic burden of toxicities associated with metastatic colorectal cancer treatment regimens containing monoclonal antibodies
Journal of Medical Economics·2011· 18 citedOpen Access
Patterns of treatment with chemotherapy and monoclonal antibodies for metastatic colorectal cancer in Western Europe
Current Medical Research and Opinion·2011· 35 cited
Major Surgery in Patients with Metastatic Colorectal Cancer in Western Europe
Journal of Gastrointestinal Cancer·2011· 12 citedOpen Access
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy
BMC Health Services Research·2011· 51 citedOpen Access
Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality
BMC Cancer·2011· 69 citedOpen Access
Characterizing Medical Care by Disease Phase in Metastatic Colorectal Cancer
Journal of Oncology Practice·2011· 30 citedOpen Access
Costs of hospital events in patients with metastatic colorectal cancer
Journal of Medical Economics·2011· 6 citedOpen Access
Cost of illness in patients with metastatic colorectal cancer
Journal of Medical Economics·2010· 40 citedOpen Access
Healthcare costs in postmenopausal women with hormone-positive metastatic breast cancer
Journal of Medical Economics·2010· 9 cited
Suboptimal Nutritional Intake for Hypertension Control in 4 Ethnic Groups
Archives of Internal Medicine·2009· 45 cited
Evaluating clinically meaningful change on the ITP-PAQ: preliminary estimates of minimal important differences
Current Medical Research and Opinion·2008· 32 cited
Modifications to the Healthy Eating Index and its ability to predict obesity: the Multi-Ethnic Study of Atherosclerosis
American Journal of Clinical Nutrition·2008· 147 citedOpen Access
Health Care Use and Costs Associated With Use of a Health Club Membership Benefit in Older Adults with Diabetes
Diabetes Care·2008· 39 citedOpen Access
Deteriorating Dietary Habits Among Adults With Hypertension
Archives of Internal Medicine·2008· 420 cited
Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective
Health and Quality of Life Outcomes·2008· 110 citedOpen Access
Reduction in immunoglobulin (IVIG or anti D) use in patients with chronic immune thrombocytopenic purpura (ITP) receiving AMG 531
Blood·2007
Health-Related Quality of Life (HRQoL) in Patients (Pts) with Chronic Immune Thrombocytopenic Purpura (ITP): Results from Two Placebo-Controlled Phase 3 Studies of AMG 531.
Blood·2007· 1 cited
Reduction in Immunoglobulin (IVIG or Anti D) Use in Patients with Chronic Immune Thrombocytopenic Purpura (ITP) Receiving AMG 531: Results from Two Phase 3 Randomized Placebo-Controlled Trials.
Blood·2007· 6 cited
page 1 of 2Next →

Frequent Co-authors

Beth Barber(10), Zhongyun Zhao(7), Janet L. Nichol(4), Susan D. Mathias(3), Rohit Borker(3), David Cella(2), Claire Snyder(2), Albert W. Wu(2), James N. George(2), Montserrat Vera‐Llonch(2), Derek Weycker(2), Andrew G. Glass(2), Gerry Oster(2), Matthew L. Maciejewski(2), Xue Song(2), Christopher W. Gregory(2), Elise M. Pelletier(2), Monali Bhosle(2), Song Wang(2), David Klingman(2)